Stents as a platform for drug delivery

Bibliography

• Hedin M. The origin of the word stent. Acta Radiol 1997;38:937-9
   PubMed Web of Science ®Google Scholar
• Kamath KR, Barry JJ, Miller KM. The Taxus (TM) drug-eluting stent: a new paradigm in controlled drug delivery. Adv Drug Deliv Rev 2006;58:412-36
   PubMed Web of Science ®Google Scholar
• Shand J, Menown I. Drug-eluting stents: the next generation. Interv Cardiol 2010;2:341-50
   Google Scholar
• Vranckx P, Serruys P, Gambhir S, Biodegradable-polymer-based, paclitaxel-eluting Infinnium(tm) stent: 9-month clinical and angiographic follow-up results from the SIMPLE II prospective multi-centre registry study. EuroIntervention 2006;2:310-17
   PubMedGoogle Scholar
• Guo Q, Guo S, Wang Z. A type of esophageal stent coating composed of one 5-fluorouracil-containing EVA layer and one drug-free protective layer: in vitro release, permeation and mechanical properties. J Control Release 2007;118:318-24
   PubMed Web of Science ®Google Scholar
• Lee DK, Kim HS, Kim KS, The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane. Gastrointest Endosc 2005;61:296-301
   PubMed Web of Science ®Google Scholar
• Chew BH, Duvdevani M, Denstedt JD. New developments in ureteral stent design, materials and coatings. Expert Rev Med Devices 2006;3:395-403
   PubMed Web of Science ®Google Scholar
• Multanen M, Tammela TLJ, Laurila M, Biocompatibility, encrustation and biodegradation of ofloxacine and silver nitrate coated poly-L-lactic acid stents in rabbit urethra. Urol Res 2002;30:227-32
   PubMed Web of Science ®Google Scholar
• Li PF, Downie D, Hwang PH. Controlled steroid delivery via bioabsorbable stent: safety and performance in a rabbit model. Am J Rhinol 2009;23:591-6
   Google Scholar
• Oberhoff M, Herdeg C, Baumbach A, Karsch KR. Stent-based antirestenotic coatings (sirolimus/paclitaxel). Catheter Cardiovasc Interv 2002;55:404-8
   PubMed Web of Science ®Google Scholar
• Lee Y-K, Hyung Park J, Tae Moon H, The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer. Biomaterials 2007;28:1523-30
   PubMed Web of Science ®Google Scholar
• Wykrzykowska JJ, Onuma Y, Serruys PW. Advances in stent drug delivery: the future is in bioabsorbable stents. Expert Opin Drug Deliv 2009;6:113-26
   PubMed Web of Science ®Google Scholar
• Miyauchi K, Kasai T, Yokayama T, Effectiveness of statin-eluting stent on early inflammatory response and neointimal thickness in a porcine coronary model. Circ J 2008;72:832-8
   PubMed Web of Science ®Google Scholar
• Waksman R. Current state of the absorbable metallic (magnesium) stent. EuroIntervention 2009;5:F94-8
   PubMedGoogle Scholar
• Grube E, Schofer J, Hauptmann K, A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer: 9-month outcomes with the JACTAX HD stent. J Am Coll Cardiol Intv 2010;3:431-8
   Google Scholar
• Grabow N, Martin DP, Schmitz KP, Sternberg K. Absorbable polymer stent technologies for vascular regeneration. J Chem Technol Biotechnol 2010;85:744-51
   Web of Science ®Google Scholar
• Matsumoto D, Shinke T, Geva S, Stent degradation of novel fully bioabsorbable salicylate-based sirolimus-eluting stent evaluated by oct in pig coronary artery. J Am Coll Cardiol 2010;55:A217
   Google Scholar
• Guo S-R, Wang Z-M, Zhang Y-Q, In vivo evaluation of 5-fluorouracil-containing self-expandable nitinol stent in rabbits: efficiency in long-term local drug delivery. J Pharm Sci 2010;99:3009-18
   PubMed Web of Science ®Google Scholar
• Lansky AJ. Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial. Circulation 2004;109:1948-54
   PubMed Web of Science ®Google Scholar
• Wessely R, Hausleiter J, Michaelis C, Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating. Arterioscler Thromb Vasc Biol 2005;25:748-53
   PubMed Web of Science ®Google Scholar
• Gunn J, Cumberland D. Stent coatings and local drug delivery – state of the art. Eur Heart J 1999;20:1693-700
   PubMed Web of Science ®Google Scholar
• Machan L. Clinical experience and applications of drug-eluting stents in the noncoronary vasculature, bile duct and esophagus. Adv Drug Deliv Rev 2006;58:447-62
   PubMed Web of Science ®Google Scholar
• Radecke M, Gerken G, Treichel U. Impact of a self-expanding, plastic esophageal stent on various esophageal stenoses, fistulas, and leakages: a single-center experience in 39 patients. Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy; New Orleans, LA; 2004. p. 812-18
   Google Scholar
• Shim C, Cho Y, Moon J, Fixation of a modified covered esophageal stent: its clinical usefulness for preventing stent migration. Endoscopy 2001;33:843-8
   PubMed Web of Science ®Google Scholar
• Grube E, Buellesfeld L. BioMatrix biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease. Expert Rev Med Devices 2006;3:731-41
   PubMed Web of Science ®Google Scholar
• Finkelstein A, McClean D, Kar S, Local drug delivery via a coronary stent with programmable release pharmacokinetics. Circulation 2003;107:777-84
   PubMed Web of Science ®Google Scholar
• Romagnoli E, Leone AM, Burzotta F, Outcomes of the tacrolimus drug-eluting Janus stent: a prospective two-centre registry in high-risk patients. J Cardiovasc Med 2008;9:589-94
   Google Scholar
• Galloni MR, Santarelli A, Pasquino E, Preclinical results of the tacrolimus-eluting Janus Carbostent. Am J Cardiol 2003;92:22L-23L
   Web of Science ®Google Scholar
• Deuse T, Erben R, Ikeno F, Introducing the first polymer-free leflunomide eluting stent. Atherosclerosis 2008;200:126-34
   PubMed Web of Science ®Google Scholar
• Mani G, Macias CE, Feldman MD, Delivery of paclitaxel from cobalt-chromium alloy surfaces without polymeric carriers. Biomaterials 2010;31:5372-84
   PubMed Web of Science ®Google Scholar
• Byrne R, Mehilli J, Iijima R, A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents. Eur Heart J 2009;30:923-31
   PubMed Web of Science ®Google Scholar
• Tada N, Virmani R, Grant G, Polymer-free biolimus A9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model. Circ Cardiovasc Interv 2010;3:174-83
   PubMed Web of Science ®Google Scholar
• Abizaid A, Costa JR. New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems. Circ Cardiovasc Interv 2010;3:384-93
   PubMed Web of Science ®Google Scholar
• Wieneke H, Dirsch O, Sawitowski T, Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits. Catheter Cardiovasc Interv 2003;60:399-407
   PubMed Web of Science ®Google Scholar
• Zilberman M, Eberhart RC. Drug-eluting bioresorbable stents for various applications. Annu Rev Biomed Eng 2006;8:153-80
   PubMed Web of Science ®Google Scholar
• Kotsar A, Isotalo T, Uurto I, Urethral in situ biocompatibility of new drug-eluting biodegradable stents: an experimental study in the rabbit. BJU Int 2009;103:1132-5
   PubMed Web of Science ®Google Scholar
• Wang XT, Venkatraman SS, Boey FYC, Controlled release of sirolimus from a multilayered PLGA stent matrix. Biomaterials 2006;27:5588-95
   PubMed Web of Science ®Google Scholar
• Grabow N, Bunger CM, Schultze C, A biodegradable slotted tube stent based on Poly(L-lactide) and poly(4-hydroxybutyrate) for rapid balloon-expansion. Ann Biomed Eng 2007;35:2031-8
   PubMed Web of Science ®Google Scholar
• Garg S, Serruys P. Coronary stents: looking forward. J Am Coll Cardiol 2010;56:S43-78
   PubMed Web of Science ®Google Scholar
• Yamawaki T, Shimokawa H, Kozai T, Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo* 1. J Am Coll Cardiol 1998;32:780-6
   PubMed Web of Science ®Google Scholar
• Vogt F, Stein A, Rettemeier G, Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent. Eur Heart J 2004;25:1330-40
   PubMed Web of Science ®Google Scholar
• Ormiston JA, Webster MWI, Armstrong G. First-in-human implantation of a fully bioabsorbable drug-eluting stent: the BVS poly-L-lactic acid everolimus-eluting coronary stent. Catheter Cardiovasc Interv 2007;69:128-31
   PubMed Web of Science ®Google Scholar
• Cottone R, Thatcher G, Parker S, OrbusNeich fully absorbable coronary stent platform incorporating dual partitioned coatings. EuroIntervention 2009;5:F65-71
   Google Scholar
• Mikkonen J, Uurto I, Isotalo T, Drug-eluting bioabsorbable stents – An in vitro study. Acta Biomater 2009;5:2894-900
   PubMed Web of Science ®Google Scholar
• Eberhart RC, Su SH, Nguyen KT, Bioresorbable polymeric stents: current status and future promise. J Biomater Sci Polym Ed 2003;14:299-1312
   PubMed Web of Science ®Google Scholar
• Lei L, Liu X, Guo S, 5-Fluorouracil-loaded multilayered films for drug controlled releasing stent application: drug release, microstructure, and ex vivo permeation behaviors. J Control Release 2010;146:45-53
   PubMed Web of Science ®Google Scholar
• Lao LL, Venkatraman SS. Paclitaxel release from single and double-layered poly(DL-lactide-co-glycolide)/poly(L-lactide) film for biodegradable coronary stent application. J Biomed Mater Res A 2008;87A:1-7
   Google Scholar
• Chew BH, Cadieux PA, Reid G, Denstedt JD. In-vitro activity of triclosan-eluting ureteral stents against common bacterial uropathogens. J Endourol 2006;20:949-58
   PubMed Web of Science ®Google Scholar
• Cauda F, Cauda V, Fiori C, Heparin coating on ureteral double J stents prevents encrustations: an in vivo case study. J Endourol 2008;22:465-72
   PubMed Web of Science ®Google Scholar
• Daemen J, Serruys P. Drug-eluting stent update 2007: Part I: a survey of current and future generation drug-eluting stents: meaningful advances or more of the same? Circulation 2007;116:316-28
   PubMed Web of Science ®Google Scholar
• Verheye S, Agostoni P, Dawkins K, The GENESIS (randomized, multicenter study of the pimecrolimus-eluting and pimecrolimus/paclitaxel-eluting coronary stent system in patients with de novo lesions of the native coronary arteries) trial. J Am Coll Cardiol 2009;2:205-14
   Google Scholar
• Huang Y, Venkatraman Subbu SSS, Boey FYC, In vitro and in vivo performance of a dual drug-eluting stent (DDES). Biomaterials 2010;31:4382-91
   PubMed Web of Science ®Google Scholar
• Pack D, Hoffman A, Pun S, Stayton P. Design and development of polymers for gene delivery. Nat Rev Drug Discov 2005;4:581-93
   PubMed Web of Science ®Google Scholar
• Walter D, Cejna M, Diaz-Sandoval L, Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation 2004;110:36-45
   PubMed Web of Science ®Google Scholar
• Wang F, Wang J, Zhai Y, Layer-by-layer assembly of biologically inert inorganic ions/DNA multilayer films for tunable DNA release by chelation. J Control Release 2008;132:65-73
   PubMed Web of Science ®Google Scholar
• Klugherz B, Jones P, Cui X, Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat Biotechnol 2000;18:1181-4
   PubMed Web of Science ®Google Scholar
• Ye YW, Landau C, Willard JE, Bioresorbable microporous stents deliver recombinant adenovirus gene transfer vectors to the arterial wall. Ann Biomed Eng 1998;26:398-408
   PubMed Web of Science ®Google Scholar
• Sun XL, Zhang N. Cationic polymer optimization for efficient gene delivery. Mini Rev Med Chem 2010;10:108-25
   PubMed Web of Science ®Google Scholar
• Lao LL, Venkatraman SS. Adjustable paclitaxel release kinetics and its efficacy to inhibit smooth muscle cells proliferation. J Control Release 2008;130:9-14
   PubMed Web of Science ®Google Scholar
• Fattori R, Piva T. Drug-eluting stents in vascular intervention. Lancet 2003;361:247-9
   PubMed Web of Science ®Google Scholar
• Fu Y, Kao WJ. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin Drug Deliv 2010;7:429-44
   PubMed Web of Science ®Google Scholar
• Cheng L, Lei L, Guo S. In vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blends. Int J Pharm 2010;387:129-38
   PubMed Web of Science ®Google Scholar
• Alexis F, Venkatraman SS, Rath SK, Boey F. In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrices. J Control Release 2004;98:67-74
   PubMed Web of Science ®Google Scholar
• Guo Q, Knight PT, Mather PT. Tailored drug release from biodegradable stent coatings based on hybrid polyurethanes. J Control Release 2009;137:224-33
   PubMed Web of Science ®Google Scholar
• Burke SE, Kuntz RE, Schwartz LB. Zotarolimus (ABT-578) eluting stents. Adv Drug Deliv Rev 2006;58:437-46
   PubMed Web of Science ®Google Scholar
• Vranckx P, Serruys P, Gambhir S, Biodegradable-polymer-based, paclitaxel-eluting Infinnium(tm) stent: 9-Month clinical and angiographic follow-up results from the SIMPLE II prospective multi-centre registry study. Euro Interv 2006;2:310-17
   Google Scholar
• Udipi K, Melder R, Mingfei C, The next generation endeavor resolute stent: role of the BioLinx(tm) polymer system. EuroInterv 2007;3:137-9
   PubMedGoogle Scholar
• Dani S, Kukreja N, Parikh P, Biodegradable-polymer-based, sirolimus-eluting Supralimus(R) stent: 6-month angiographic and 30-month clinical follow-up results from the Series I prospective study. Euro lnterv 2008;4:59-63
   Google Scholar
• Venkatraman S, Poh TL, Vinalia T, Collapse pressures of biodegradable stents. Biomaterials 2003;24:2105-111
   PubMed Web of Science ®Google Scholar
• Kataoka T, Grube E, Honda Y, 7-Hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE). Circulation 2002;106:1788-93
   PubMed Web of Science ®Google Scholar
• Serruys P, Ormiston J, Sianos G, Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. J Am Coll Cardiol 2004;44:1363-7
   PubMed Web of Science ®Google Scholar
• Kwok O, Chow W, Law T, First human experience with angiopeptin-eluting stent: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Catheter Cardiovasc Interv 2005;66:541-6
   PubMed Web of Science ®Google Scholar
• Huang Y, Salu K, Liu X, Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model. Heart 2004;90:195-9
   PubMed Web of Science ®Google Scholar
• Ruef J, Storger H, Schwarz F, Haase J. Comparison of a polymer-free rapamycin-eluting stent (YUKON) with a polymer-based paclitaxel-eluting stent (TAXUS) in real-world coronary artery lesions. Catheter Cardiovasc Interv 2008;71:333-9
   PubMed Web of Science ®Google Scholar
• Hamilos M, Ostojic M, Beleslin B, Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion. J Am Coll Cardiol 2008;51:2123-9
   PubMed Web of Science ®Google Scholar
• Serruys P, Garg S, Abizaid A, A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study. EuroIntervention 2010;6:195-205
   PubMed Web of Science ®Google Scholar
• Rutsch W, Schhlen H, Witzenbichler B, Multicenter first-in-man study with the lowest known dose elixir myolimus-eluting coronary stent system with durable polymer: 12-month clinical and six month angiographic and IVUS follow-up. J Am Coll Cardiol 2009;53:A45
   Web of Science ®Google Scholar
• Tamburino C, Di Salvo M, Capodanno D, Real world safety and efficacy of the Janus Tacrolimus-Eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting Stent (TEST) registry. Catheter Cardiovasc Interv 2009;73:243-8
   PubMed Web of Science ®Google Scholar
• Karatas OF, Cimentepe E, Bayrak O, Unal D. A new application for urethral strictures: tacrolimus-eluting stent. J Endourol 2010;24:1043-4
   PubMed Web of Science ®Google Scholar
• Nakazawa G, Fau - Finn AV, Finn Av Fau - John MC, The significance of preclinical evaluation of sirolimus-, paclitaxel-, and. Am J Cardiol 2007;100:36M-44M
   PubMed Web of Science ®Google Scholar
• Burke S, Kuntz R, Schwartz L. Zotarolimus (ABT-578) eluting stents. Adv Drug Deliv Rev 2006;58:437-46
   PubMed Web of Science ®Google Scholar
• Konig A, Leibig M, Rieber J, Randomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome: serial angiographic and sonographic analysis. Am Heart J 2007;153:979.e1-8
   PubMedGoogle Scholar
• Shin JH, Song HY, Seo TS, Influence of a dexamethasone-eluting covered stent on tissue reaction: an experimental study in a canine bronchial model. Eur Radiol 2005;15:1241-9
   PubMed Web of Science ®Google Scholar
• Seo TS, Oh JH, Park YK, Efficacy of a dexamethasone-eluting nitinol stent on the inhibition of pseudointimal hyperplasia in a transjugular intrahepatic portosystemic shunt: an experimental study in a swine model. Korean J Radiol 2005;6:241-7
   PubMed Web of Science ®Google Scholar
• Beijk M, Piek J. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent. Expert Rev Med Devices 2007;4:11-21
   PubMed Web of Science ®Google Scholar
• Sarisozen C, Arica B, Hincal AA, Calis S. Development of biodegradable drug releasing polymeric cardiovascular stents and in vitro evaluation. J Microencapsul 2009;26:501-112
   PubMed Web of Science ®Google Scholar
• Sternberg K, Kramer S, Nischan C, In vitro study of drug-eluting stent coatings based on poly(L-lactide) incorporating cyclosporine A-drug release, polymer degradation and mechanical integrity. J Mater Sci Mater Med 2007;18:1423-32
   PubMed Web of Science ®Google Scholar
• El-Feky MA, El-Rehewy MS, Hassan MA, Effect of ciprofloxacin and N-acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces. Pol J Microbiol 2009;58:261-7
   PubMed Web of Science ®Google Scholar
• Duckers H, Onuma Y, Benit E, Final results of the HEALING 2B trial to evaluate a bioengineered CD34 antibody coated stent (Genous Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients. Circulation 2008;118:S_1042-b-3
   Google Scholar
• Pendyala L, Li JS, Yin XH, Superiority of polymer-free cerivastatin-eluting stent over polymer-based paclitaxel-eluting stent for neointimal inhibition and vasomotor function preservation in rabbit iliac arteries. Am J Cardiol 2009;104:180D-D
   Web of Science ®Google Scholar
• Scheller B, Schmitt A, Bohm M, Nickenig G. Atorvastatin stent coating does not reduce neointimal proliferation after coronary stenting. Z Kardiol 2003;92:1025-8
   PubMedGoogle Scholar
• Young JH, Myung HJ, Sang RL, Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model. J Korean Med Sci 2007;22:802-9
   PubMed Web of Science ®Google Scholar
• New G, Moses JW, Roubin GS, Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model. Catheter Cardiovasc Interv 2002;57:266-71
   PubMed Web of Science ®Google Scholar
• Acharya G, Park K. Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev 2006;58:387-401
   PubMed Web of Science ®Google Scholar
• Ding NI, Pacetti SD, Tang F-W, XIENCE V™ Stent design and rationale. J Interv Cardiol 2009;22:S18-27
   Web of Science ®Google Scholar
• de Ribamar Costa J Jr, Abizaid A. Novolimus™-eluting coronary stent system. Interv Cardiol 2010;2:645-9
   Google Scholar
• Holmes D. Interventional cardiology: a new drug-eluting stent that does not live up to its promise. Nat Rev Cardiol 2009;6:500-1
   PubMed Web of Science ®Google Scholar
• Ashok S. Moving towards biomimicry-the development of the novel BioMime™ sirolimus-eluting coronary stent system. Eur Cardiol 2010;6:78-82
   Google Scholar
• Botelho R, Verheye S, Whitbourn R, Clinical experience with a sirolimus-eluting nitinol stent in a biodegradable polymer matrix using the cardiomind (R) 0.014''sparrow (R) stent system. J Am Coll Cardiol 2010;55:A217.E2061
   Google Scholar
• Costa J Jr, Abizaid A, Costa R, Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions: a first-in-human analysis of a third-generation drug-eluting stent system. J Am Coll Cardiol Intv 2008;1:545-51
   Google Scholar